STOCK TITAN

LXEO (NASDAQ: LXEO) affiliate plans sale of 4,867 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LXEO affiliate files to sell 02/17/2026 a total of 4,867 common shares under a Form 144 notice. The filing states these shares arise from restricted stock vesting and were designated as compensation.

The filing also discloses 615 shares sold during the prior three months (date 11/18/2025). Timing and specific broker execution details are provided in the notice.

Positive

  • None.

Negative

  • None.

Insights

Routine affiliate resale notice of vested restricted shares; administrative disclosure.

The filing lists 4,867 common shares to be sold on 02/17/2026, described as resulting from restricted stock vesting and designated as compensation. This is an SEC notice required when affiliates plan resales.

Prior activity shows 615 shares sold on 11/18/2025. Cash‑flow treatment and final execution details are not specified in the excerpt; subsequent broker reports may show completed trades.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does LXEO's Form 144 report disclose?

The filing discloses a planned sale of 4,867 common shares dated 02/17/2026, arising from restricted stock vesting. It also reports 615 shares sold on 11/18/2025 during the prior three months.

Who is the reported seller in the LXEO Form 144?

The Form lists an affiliate linked to an account at Fidelity Brokerage Services LLC and identifies the related individual address for the reporting person. The excerpt ties the shares to restricted stock vesting and compensation.

How many LXEO shares were sold in the prior three months?

The report states 615 shares were sold on 11/18/2025. This figure appears in the "Securities Sold During The Past 3 Months" section of the notice and is reported as prior disposition activity.

Are the LXEO shares being sold by issuance or secondary resale?

The filing describes the 4,867 shares as resulting from restricted stock vesting and labeled "Compensation," indicating these vested shares are the subject of the proposed resale rather than a new primary issuance.
Lexeo Therapeutics Inc

NASDAQ:LXEO

LXEO Rankings

LXEO Latest News

LXEO Latest SEC Filings

LXEO Stock Data

457.63M
67.58M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
NEW YORK